Pura Vida Investments, LLC Revance Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

  • $145 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$23.23 - $34.3 $950,107 - $1.4 Million
-40,900 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$12.6 - $26.55 $515,340 - $1.09 Million
40,900 New
40,900 $999,000
Q4 2017

Feb 14, 2018
SELL
$24.55 - $36.3 $1.23 Million - $1.81 Million
-50,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$22.55 - $28.1 $1.13 Million - $1.41 Million
50,000
50,000 $1.38 Billion

Others Institutions Holding RVNC

# of Institutions
232
Shares Held
82.1M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email